Verified Nov 2026
Batteries & E-Mobility
·
Ans, Walloon Region
·
Since 2004
Trasis, founded in 2004 and headquartered in Ans, Belgium, develops automated synthesizers, dose preparation systems, and regulatory support solutions for radiopharmaceutical production. With approximately 380 employees, the company serves the nuclear medicine, medical device, and related industrial sectors. It exports over 98% of its output to more than 60 countries and acquired a pharmaceutical production facility in Flémalle in May 2026 as part of its expansion strategy.
Trasis at a glance
Employees
200-500
Founded
2004
Headquarters
Ans, Walloon Region
Industries
Automotive
Electric Vehicles
Medical
Plumbing & Hardware
Industrial Equipment
Overview
Trasis, founded in 2004 and headquartered in Ans, Belgium, develops automated synthesizers, dose preparation systems, and regulatory support solutions for radiopharmaceutical production. With approximately 380 employees, the company serves the nuclear medicine, medical device, and related industrial sectors. It exports over 98% of its output to more than 60 countries and acquired a pharmaceutical production facility in Flémalle in May 2026 as part of its expansion strategy.
At a glance
Attribute | Detail |
|---|---|
Founded | 2004 |
Headquarters | Ans, Walloon Region |
Employees | 200-500 |
Primary capability | Batteries & E-Mobility |
What Trasis makes
The company manufactures automated radiopharmaceutical synthesizers and provides quality control, dose preparation equipment, and consulting services for theranostics development and regulatory compliance.
Latest developments
2026-05-20 — Le groupe Trasis reprend le site de production pharmaceutique de Mithra CDMO à Flémalle | AKTus – CCI (aktus-cci.be)
2026-05-19 — Trasis reprend l'ancien site de production pharmaceutique de Mithra à Flémalle - La Libre (lalibre.be)
2026-05-19 — Trasis Group is taking a new step in its industrial growth. | Trasis (linkedin.com)
2025-12-18 — VVR International advises TRASIS on the acquisition of its distributor and the creation of its joint venture in China - VVR International, développement stratégique, production, sourcing, distribution… (vvrinternational.com)
2025-11-25 — Trasis renforce sa présence en Chine avec Trasis Beijing - RTBF Actus (rtbf.be)
2025-11-24 — Trasis and Beijing PET Technology strengthen long-term partnership with new joint venture to support nuclear medicine in China | Trasis (trasis.com)
Company details
Trasis reported €72 million in sales in 2024 and has established a joint venture in China to strengthen its presence in that market. Trasis was founded in 2004, has an estimated 200-500 employees, and is headquartered in Ans, Walloon Region.
Frequently asked questions
What does Trasis make?
Trasis, founded in 2004 and headquartered in Ans, Belgium, develops automated synthesizers, dose preparation systems, and regulatory support solutions for radiopharmaceutical production. With approximately 380 employees, the company serves the nuclear medicine, medical device, and related industrial sectors. It exports over 98% of its output to more than 60 countries and acquired a pharmaceutical production facility in Flémalle in May 2026 as part of its expansion strategy.
Where is Trasis headquartered?
Trasis is headquartered in Ans, Walloon Region.
When was Trasis founded?
Trasis was founded in 2004.
How big is Trasis?
Trasis has an estimated 200-500 employees.
Related suppliers
Explore other suppliers in the LightSource directory:
Last verified Nov 2026. Is this your company? Request a correction.
Location & contact
Evaluating suppliers like these?
This profile is part of a public-data sample of the full LightSource directory. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.
